Skip to main content

Table 1 Demographic data of aPC and no-aPC patients

From: The aPC treatment improves microcirculation in severe sepsis/septic shock syndrome

  

aPC group (n = 13)

No-aPC group (n = 9)

p

Gender

Male: Female

10:3

5:4

ns

Age

Median (min-max)

54 (31–77)

61 (34–84)

ns

APACHE II a

Median (min-max)

26 (16–40)

29 (20–36)

ns

28-day mortality

Survivors

8

5

ns

 

Non-survivors

5

4

ns

Baseline disease

Trauma

5

3

ns

 

COPDb

1

1

ns

 

Pneumonia

2

1

ns

 

Tiroidectomy

1

-

ns

 

Septic shock

4

2

ns

 

AAAc

-

1

ns

Source of sepsis

Lung

5

4

ns

 

Urinary tract

2

1

ns

 

Abdomen

3

2

ns

 

Blood

3

2

ns

Pathogen

Gram -

9

7

ns

 

Gram +

4

2

ns

  1. aAcute Physiology and Chronic Health Evaluation II score.
  2. bChronic Obstructive Pulmonary Disease.
  3. cAbdominal Aortic Aneurismectomy.
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us